Literature DB >> 18432389

Alcohol consumption and HIV-1 vaginal RNA shedding among women.

Katherine P Theall1, Angela Amedee, Rebecca A Clark, Jeanne Dumestre, Patricia Kissinger.   

Abstract

OBJECTIVE: The purpose of this study was to examine the association between alcohol consumption and HIV-1 vaginal shedding.
METHOD: HIV-1 infected women attending a large urban HIV primary care clinic in New Orleans, LA, between June 2002 and October 2004 who underwent a gynecological exam, were 18 years of age or older, and provided informed consent were included. Subjects underwent exams and were interviewed using a computer-assisted survey at baseline, 1 month, and 3 months.
RESULTS: Most of the women were black (86.4%), with a median age of 38 (range: 19-61 years). Most (56.7%) also were on antiretroviral therapy (ART; with 89.6% self-reported adherence) and had a median CD4 of 404 copies/ml and a plasma viral load of 13,400 copies/ml at baseline. The overall period prevalence of vaginal shedding (>50 copies/swab) was 24.5%, with a baseline prevalence of 27.3%. At baseline, 30% reported any alcohol consumption, 32.6% were weekly drinkers, 25.5% were heavy episodic drinkers, and 10.0% had recent moderate to heavy alcohol consumption (two or more drinks the day before the interview). Recent moderate to heavy alcohol consumption and heavy episodic drinking were both strongly and positively associated with vaginal shedding but only among women on ART. After adjusting for plasma viral load, immunosuppression, and ART adherence, recent moderate to heavy alcohol consumption was significantly associated with vaginal shedding (adjusted prevalence odds ratio=2.29, 95% confidence interval: 1.18-14.43). No association was observed for plasma viral load and alcohol consumption.
CONCLUSIONS: Recent alcohol consumption was associated with expression of HIV-1 RNA in vaginal fluids of women on ART. Future research is needed to support this observation and to determine the mechanisms behind it.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18432389     DOI: 10.15288/jsad.2008.69.454

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  15 in total

Review 1.  Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of the literature.

Authors:  Jennifer L Brown; Kelly S DeMartini; Jessica M Sales; Andrea L Swartzendruber; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

2.  Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort.

Authors:  Judith A Hahn; Debbie M Cheng; Nneka I Emenyonu; Christine Lloyd-Travaglini; Robin Fatch; Starley B Shade; Christine Ngabirano; Julian Adong; Kendall Bryant; Winnie R Muyindike; Jeffrey H Samet
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-15       Impact factor: 3.731

3.  Elevated urinary leukocyte esterase as a potential surrogate marker for HIV sexual transmission risks in men receiving antiretroviral therapy.

Authors:  Seth C Kalichman; Christopher Washington; Tamar Grebler; Moira O Kalichman; Chauncey Cherry; Lisa Eaton
Journal:  Int J STD AIDS       Date:  2014-05-27       Impact factor: 1.359

4.  The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques.

Authors:  Nisha Loganantharaj; Whitney A Nichols; Gregory J Bagby; Julia Volaufova; Jason Dufour; David H Martin; Steve Nelson; Angela M Amedee
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

Review 5.  Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model.

Authors:  Patricia E Molina; Angela M Amedee; Peter Winsauer; Steve Nelson; Gregory Bagby; Liz Simon
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-21       Impact factor: 4.147

6.  Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.

Authors:  James Homans; Shawna Christensen; Tracey Stiller; Chia-Hao Wang; Wendy Mack; Kathryn Anastos; Howard Minkoff; Mary Young; Ruth Greenblatt; Mardge Cohen; Howard Strickler; Roksana Karim; Lashonda Yvette Spencer; Eva Operskalski; Toinette Frederick; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2012-05-01       Impact factor: 3.731

7.  Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006.

Authors:  Robert L Cook; Fang Zhu; Bea Herbeck Belnap; Kathleen Weber; Judith A Cook; David Vlahov; Tracey E Wilson; Nancy A Hessol; Michael Plankey; Andrea A Howard; Stephen R Cole; Gerald B Sharp; Jean L Richardson; Mardge H Cohen
Journal:  Am J Epidemiol       Date:  2009-03-06       Impact factor: 4.897

Review 8.  Biomedical consequences of alcohol use disorders in the HIV-infected host.

Authors:  Patricia E Molina; Gregory J Bagby; Steve Nelson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

Review 9.  Alcohol and HIV Effects on the Immune System.

Authors:  Gregory J Bagby; Angela M Amedee; Robert W Siggins; Patricia E Molina; Steve Nelson; Ronald S Veazey
Journal:  Alcohol Res       Date:  2015

10.  Enhanced oxidative stress by alcohol use in HIV+ patients: possible involvement of cytochrome P450 2E1 and antioxidant enzymes.

Authors:  Anusha Ande; Namita Sinha; P S S Rao; Carole P McArthur; Leo Ayuk; Paul N Achu; Annette Njinda; Anil Kumar; Santosh Kumar
Journal:  AIDS Res Ther       Date:  2015-09-22       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.